R7 OceansBio

Currently, electronic drugs all use primary batteries, and batteries account for about three quarters of electronic drugs due to EMI problems.

As a result, implantation in vivo is not very comfortable, and in the case of epilepsy, the device has a life span of 10 years, but some people think that it can only be used for 6 months to 5 years.

This means that some patients need surgery every six months.

So we are developing an electroceutical device with wireless charging capabilities.